Ustekinumab‐induced drug eruption resembling lymphocytic infiltration (of Jessner–Kanof) and lupus erythematosus tumidus
- 29 December 2015
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 81 (4) , 792-794
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- SCIENTIFIC ABSTRACTS - 17th Annual Las Vegas Dermatology SeminarSeminars in Cutaneous Medicine and Surgery, 2016
- What Happened after the Clinical Trials: Long-Term Safety and Efficacy of Ustekinumab in Daily Clinical PracticeDermatology, 2014
- Duloxetine-induced Pseudolymphoma with Features of Lymphocytic Infiltration of Jessner-KanofActa Dermato-Venereologica, 2014
- Jessner–Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus?Rheumatology International, 2009
- Lymphocytic Infiltration of the Skin Jessner-Kanof After Treatment With a Hydroquinone-Containing Bleaching CreamArchives of Dermatology, 2006
- Could Jessner’s Lymphocytic Infiltrate of the Skin Be a Dermal Variant of Lupus Erythematosus? An Analysis of 210 CasesDermatology, 2006
- Jessner-Kanof lymphocytic infiltration of the skin associated with glatiramer acetateMultiple Sclerosis Journal, 2005
- ACE-Inhibitor-Induced Drug Eruption Resembling Lymphocytic Infiltration (of Jessner-Kanof) and Lupus erythematosus tumidusDermatology, 2004
- Histopathologic findings in lupus erythematosus tumidus: Review of 80 patientsJournal of the American Academy of Dermatology, 2003
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981